RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 TRILOGY ACS Outcomes
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 13
SP 12
OP 12
DO 10.1177/155989771213004
UL http://mdc.sagepub.com/content/12/13/12.abstract
AB In the largest trial to date of patients with medically managed acute coronary syndrome without revascularization, prasugrel did not improve outcomes, compared with clopidogrel during 2.5 years of follow-up among patients <75 years. The findings are from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes [TRILOGY ACS] study [Roe MT et al. N Engl J Med 2012].